A carregar...
Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma
BACKGROUND: Pancreatic carcinoma possesses one of the highest lethality rates, highest drug-resistance, and highest incidence rates. The objective of this research was to enhance the efficacy and drug-resistance for pancreatic carcinoma by using inhibition of SIRT1 combined with gemcitabine therapy...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3718766/ https://ncbi.nlm.nih.gov/pubmed/23898224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S45064 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|